Advertisement

Banner Fairtec GmbH Worldwide Event Solutions 600x60px
All >

Deals > Germany

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Germany or involving German organisations.

Total search results: 6302 | Ordered by Date (descending)
next pagenext page 1 2 3 4 ... 62 63 64  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Strüngmann Group–Formycon: biosimilar, 201312– license ww excl to first biosimilar in Formycon’s pipeline to Santo Holding GmbH 2013-12-12
Bayer–Druggability Technologies: drug delivery technology, 201312– collab multi-year to deploy Super-API platform to Bayer HealthCare molecules 2013-12-05
FN Semillas–Bayer: investment, 201312 acquisition €na by Bayer CropScience 2013-12-05
Sonic Healthcare–Ariosa Diagnostics: Harmony Prenatal Test, 201312– supply Sonic Healthcare will offer test via Bioscientia in Germany 2013-12-05
Euroimmun–Mecklenburg-Vorpommern (govt): grant, 201312– grant €3.15m to support total Euroimmun €14m investment to expand Dassow facility 2013-12-04
Pfizer–Protagen: biomarker discovery services, 201312– collab use SeroTag process to identify markers for autoimmune drug developm 2013-12-03
Paion–Capital Ventures International: investment, 201312–201402 private placement €6.17 acquisition 2.55m new shares in 2 tranches by CVI 2013-12-01
TocopheRx–Merck (DE): investment, 201312 seed financing $3.2m from MS Ventures for spin-off from Merck Serono 2013-12-01
Algeta–Bayer: investment, 201311– acquisition proposal by Bayer NOK362/share valuing Algeta equity at €2.1b 2013-11-26
R-Pharm–Paion: remimazolam, 201310– license excl €1m upfront + €3m milestones + royalties for developm + manuf + marketing in Russia + CIS 2013-11-26
R-Pharm–Paion: remimazolam, 201311– license €1m upfront + €3m milestones + royalties for developm + marketing in Turkey to TR-Pharm 2013-11-26
Boehringer–Galapagos: drug discovery, 201311– supply integrated drug discovery services by BioFocus to undisclosed Boehringer target 2013-11-20
Definiens–Affect: public relations, 201311 service existent by Affect Inc 2013-11-20
Global Bioenergies–Germany (govt): grant, 201311– BMBF grant €5.7m for Global Bioenergies GmbH within BioEconomy programme 2013-11-20
Merck (DE)–Biopharm: therapeutic protein, 201311– collab €na r+d biopharmaceutical for osteoarthritis with Merck Serono 2013-11-20
Metamark Genetics–Definiens: image analysis s/w, 201311– collab + supply multi-year agreem to use Cognition Network Technology with ProMark test 2013-11-20
CI3 Cluster–AbbVie: personalised immunotherapy, 201311 collab existent AbbVie Deutschland GmbH & Co KG is cluster partner 2013-11-19
CI3 Cluster–Bayer: personalised immunotherapy, 201311 collab existent Bayer Vital GmbH is cluster partner 2013-11-19
CI3 Cluster–Biopharm: personalised immunotherapy, 201311 collab existent PW Technologies GmbH is cluster partner 2013-11-19
CI3 Cluster–Dr Falk Pharma: personalised immunotherapy, 201311 collab existent Dr Falk Pharma GmbH is cluster partner 2013-11-19
CI3 Cluster–GenXPro: personalised immunotherapy, 201311 collab existent GenXPro GmbH is cluster partner 2013-11-19
CI3 Cluster–Infraserv Höchst: personalised immunotherapy, 201311 collab existent Infraserv GmbH & Co Hoechst KG is cluster partner 2013-11-19
CI3 Cluster–itechpartners: personalised immunotherapy, 201311 collab existent itechpartners – Dr Rainer Wessel is cluster partner 2013-11-19
CI3 Cluster–Medatixx: personalised immunotherapy, 201311 collab existent Medatixx GmbH & Co KG is cluster partner 2013-11-19
CI3 Cluster–Medesso: personalised immunotherapy, 201311 collab existent Medesso GmbH is cluster partner 2013-11-19
CI3 Cluster–Molekularpathologie Trier: personalised immunotherapy, 201311 collab existent ProteoPath GbR is cluster partner 2013-11-19
CI3 Cluster–thinXXS Microtechnology: personalised immunotherapy, 201311 collab existent thinXXS Microtechnology AG is cluster partner 2013-11-19
Scopis–High-Tech Gründerfonds: investment, 201311 financing round Series A incl returning investor HTGF 2013-11-19
Scopis–SEVERAL: investment, 201311 financing round Series A from HTGF + VC Fonds Technologie Berlin + Falk Strascheg + Fraunhofer 2013-11-19
Strüngmann Group–SEVERAL: investment, 201311 Ganymed financing round Series E €45m from existing investors ATS + MIG Fond + FCPB Gany GmbH 2013-11-18
Merck (DE)–BeiGene: cancer drug, 201311– license ww + collab co-developm + commercialisation of PARP inhibitor BeiGene-290 by Merck Serono 2013-11-13
R-Biopharm–Candor Bioscience: immunoassays, 201311– strategic alliance in the area of companion diagnostics 2013-11-13
Roche–Immatics: cancer immunotherapy, 201311– strategic r+d collab €17m upfront + research funding + >€1b milestones to develop cancer vaccines 2013-11-13
Coral BioNet–Wacker: investment, 201311– acquisition 100% of Scil Proteins Production GmbH by Wacker Biotech GmbH from BioNet Ventures GmbH 2013-11-12
MeVis–PERSON: investment, 201311 shareholding of voting rights of Carl JG Evertsz has fallen to 14.995% 2013-11-11
JnJ–Evotec: drug discovery services, 201311– collab drug target discovery for Alzheimer drugs with JnJ Innovation Centre California 2013-11-08
Hookipa Biotech–Boehringer: investment, 201311 financing round Series B totalling €20m incl new + co-investor BIVF 2013-11-04
Merck (DE)–Kadimastem: drug discovery services, 201311– collab MOU drug screening + discovery for neurodegenerative disesases Merck Serono 2013-11-04
Strüngmann Group–4SC: drug discovery services, 201311– collab discovery + optimis small molecule anti-infectives by 4SC Discovery+Crelux for AiCuris 2013-11-04
Thermo Fisher–Univ Utrecht: mass spectrometry, 201311– collab developm applications + appointm of A Makarov as Professor 2013-11-04
AlBioTex project–Germany (govt): grant, 201311– BMBF co-funding for research project on microbial production of biopolymers for medtech + textiles 2013-11-01
CRM Clinical Trials–Venn Life Sciences: investment, 201310 acquisition €0.6m in shares ANNOUNCED 2013-10-31
IROA Technologies–Bruker Corp: mass spectrometer, 201310 supply existent IROA uses Bruker MS for metabolomics research 2013-10-31
Merck (DE)–Max Planck: drug discovery services, 201310– collab 5y strategic partnership of Merck Serono with Lead Discovery Center GmbH 2013-10-31
Ako med–Curetis: Unyvero system, 201310 distribution existent Ako med doo is distributor in countries of former Yugoslavia for system + cartridges 2013-10-30
BioLine (RU)–Curetis: Unyvero system, 201310 distribution existent BioLine LLC is Russian distribution partner for system + cartridges 2013-10-30
BioChain–Epigenomics: molecular diagnostics, 201310– broad strategic collaboration expanding prior license agreement for China 2013-10-28
Cell Signaling Technology–RainDance: RainDrop Digital PCR System, 201310– distribution by BIOKÉ in Germany + Benelux 2013-10-28
Epigenomics–BioChain: investment, 201310 acquisition €0.94m ($1.3m) of 217.9k new shares as part of strategic collaboration 2013-10-28
Formycon–SEVERAL: investment, 201310–201312 capital increase €9.4m 1.257m new common shares €7.5/share to existent shareholders 2013-10-28
Genetrix (ES)–SEVERAL: investment, 201310 rights offering + private placement of Sygnis AG €2.7m with 1.02m new shares €2.65/share 2013-10-28
Hana Pharmaceuticals–Paion: remimazolam, 201310– license excl €1m upfront + €2m milestones + 10% royalties for dev + manuf + commerc in Korea 2013-10-28
Biotest–SEVERAL: credit, 201310– placing of €210m notes in different tranches to more than 70 investors 2013-10-24
Celesio–McKesson: investment, 201310– acquisition €6.1b with acqu of 50.01% shares from Haniel + cash tender offer for all remaining shares €23/share 2013-10-23
Boehringer–Beactica: drug discovery services, 201310– collab expansion €na fragment-based drug discovery services for oncology-relevant kinases 2013-10-22
Heraeus–Curetis: molecular diagnostics, 201310 collab existent co-developm + co-marketing of Unyvero i60 ITI application 2013-10-22
AstraZeneca–Evotec: kidney disease drugs, 201310– license + collab agreem €na giving AZ access to selected series of molecules to treat CKD 2013-10-21
Clovis Oncology–Qiagen: molecular companion diagnostics, 201310– collab developm of therascreen EGFR RGQ PCR Kit for CO-1686 2013-10-21
Mérieux–MC Services: public relations, 201310 service existent for Transgene SA 2013-10-21
Austria (govt)–Biocom: publishing, 201310 supply service with regard to Vienna Life Science Report 2013/14 to LISAvienna by Biocom 2013-10-17
Boehringer–Vector Capital: drug discovery s/w, 201310– supply Certara D360 as drug discovery platform in Ridgefield + Biberach + Vienna 2013-10-17
Suzhou SJ Biomaterials–Scienion: print/spotting technology, 201310– distribution of Scienion products in China by Suzhou SJ Biomaterials Co Ltd 2013-10-17
Sygnature Discovery–Proteros: drug discovery services, 201310– collab strategic alliance to offer integrated services incl X-ray structure analysis 2013-10-17
Photonics Healthcare–Bavaria (govt): investment, 201310 1st financing round led by HTGF + Bayern Kapital 2013-10-16
Photonics Healthcare–High-Tech Gründerfonds: investment, 201310 1st financing round led by HTGF + Bayern Kapital 2013-10-16
Photonics Healthcare–SEVERAL: investment, 201310 1st financing round led by HTGF + Bayern Kapital 2013-10-16
CV genes-at-target project–Evotec: genomic drug target discovery, 2013– collab European ScreeningPort is partner in FP7 project 2013-10-15
CV genes-at-target project–Univ Lübeck: genomic drug target discovery, 2013– collab Univ of Lübeck is partner in FP7 project 2013-10-15
Immatics–SEVERAL: investment, 201310 financing round Series D 1st tranche €12m of €34m round Hopp + Strüngmann + Wellington Partners + MIG Funds 2013-10-15
Bayer–BioInvent: antibody library, 201310 license €na extension + broadening to n-CoDeR libraries for development of therapeutic antibodies 2013-10-14
Wilex–MC Services: public relations, 201310 service existent for Wilex AG 2013-10-10
Bayer–RWTH Aachen: bioinformatics, 201310– collab founding of Joint Research Center on Computational Biomedicine by BTS + RWTH 2013-10-09
Bayer–Sysmex: molecular companion diagnostics, 201310– collab master agreem for developm of blood-based CDx for cancer drugs by Sysmex Inostics 2013-10-09
Sartorius–PERSON: investment, 201310 existent family of the late Horst Satorius owns 50.09% bound by last will of Horst Satorius 2013-10-09
Schott–Sony: slides, 201310 collab developm + marketing of glass-plastic hybrid cell imaging slide 2013-10-07
JnJ–CureVac: vaccine technology, 201310– collab + license €na use of RNActive technology for developm of mRNA-based influenza vaccine with Crucell 2013-10-03
Merus–Akampion: public relations, 201310 service existent by Akampion 2013-10-03
Findeisen Laborbedarf–Omnilab (DE): investment, 201310 acquisition of Findeisen Laborbedarf GmbH by Omnilab-Laborzentrum GmbH & Co KG 2013-10-01
Analytik Jena–Endress+Hauser: investment, 201309– mandatory offer for remaining 52.67% of shares for €13.75/share 2013-09-27
Analytik Jena–PERSON: investment, 201309 existent founder + CEO Klaus Berka owns 9.93% 2013-09-27
Merck (DE)–Ablynx: Nanobodies, 201309– collab co-discovery + co-developm Nanobodies extension Merck Serono 2013-09-26
Panoptes Pharma–4SC: investment, 201309 4SC Discovery receives 24.9% share in Panoptics as part of license for PP-001 2013-09-26
Panoptes Pharma–4SC: PP-001, 201309– license for inflammatory eye diseases against 24.9% share in Panoptes plus milestones + royalties 2013-09-26
Indivumed–Sysmex: investment, 201309–201310 acquisition of 100% of Inostics GmbH + its subsidiary Inostics Inc by Sysmex Corp 2013-09-25
Partec–Sysmex: investment, 201309 acquisition of Partec GmbH by Sysmex Corp 2013-09-24
Myelo Therapeutics–Berlin (govt): investment, 201309 financing round Series A incl VC Fonds Technologie Berlin 2013-09-23
Myelo Therapeutics–Eckert Wagniskapital: investment, 201309 financing round Series A incl Eckert Wagniskapital und Frühphasenfinanzierung GmbH 2013-09-23
Myelo Therapeutics–JSC Valenta Pharmaceuticals: investment, 201309 financing round Series A incl JSC Valenta Pharmaceuticals 2013-09-23
Myelo Therapeutics–SEVERAL: investment, 201309 financing round Series A from VC Fonds Technologie Berlin + Eckert Wagniskapital + JSC Valenta 2013-09-23
IKFE–Columbia Healthcare Services: investment, 201309 acquisition 100% of IKFE Services GmbH which continues business of bankrupt IKFE Institut 2013-09-18
MorphoSys–SEVERAL: investment, 201309 private placement €84m with 1.5m new shares €55.76/share to institutional investors 2013-09-18
Evonik–Genedata: bioinformatics, 201309– collab expansion use of integrated Genedata offering incl Genedata Selector 2013-09-17
Microstim–SEVERAL: investment, 201309 financing round €500k MVP + HTGF + Fides Finanz-Invest 2013-09-17
Affimed–MC Services: public relations, 201309 service existent for Affimed Therapeutics AG 2013-09-16
Bruker Corp–Siscapa: SISCAPA assay technology, 201309– collab extension developm SISCAPA-MALDI workflows + installation in demo facility 2013-09-16
Rhön-Klinikum–Fresenius: investment, 201309– acquisition of 43 German hospitals for €3.07b by Fresenius Helios ANNOUNCED 2013-09-13
Evotec–Harvard Univ: drug discovery, 201309– collab €na drug discovery for ALS using iPS cells with HSCI 2013-09-12
Bayer–MIT: personalised cancer drugs, 201309– collab 5y discovery + development using oncogenomics with Broad Institute 2013-09-10
Neurodyn–Galantos: galantamine, 201309 acquisition of all assets related to Memogain® formulation of galantamine by Neurodyn 2013-09-09
Analytik Jena–Endress+Hauser: investment, 201309 capital increase €24.4m incl Endress+Hauser with resulting direct + indirect 47.33% share for E+H 2013-09-04
next pagenext page 1 2 3 4 ... 62 63 64  next pagenext page



Advertisement

The Events Group Pharm Connect Congress 2015 Budapest February 600x60px

To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to info@iito.de and simply fill the subject line with the word »LSG newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Banner Fairtec GmbH We Optimise the ROI of Your Event 600x60px

» top

Advertisements

SunChrom Job Offering Product Manager MALDI Imaging 120x240px The Events Group Pharm Connect Congress 2015 Budapest February 120x180px Highl Successful LC/MS Niche Player Is Looking for a Junior Partner 120x240px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Banner [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px